

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerulus development (GO:0032835) | 6.10908813 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.96026295 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 4.70476825 |
| 4 | lymphangiogenesis (GO:0001946) | 4.37223954 |
| 5 | epithelial cell differentiation involved in kidney development (GO:0035850) | 4.20553385 |
| 6 | lymph vessel development (GO:0001945) | 4.12699515 |
| 7 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.12203893 |
| 8 | positive regulation of protein kinase C signaling (GO:0090037) | 3.93513889 |
| 9 | renal filtration (GO:0097205) | 3.77551042 |
| 10 | keratan sulfate catabolic process (GO:0042340) | 3.74883604 |
| 11 | regulation of axon guidance (GO:1902667) | 3.64122515 |
| 12 | positive regulation of p38MAPK cascade (GO:1900745) | 3.62748211 |
| 13 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.60787124 |
| 14 | barbed-end actin filament capping (GO:0051016) | 3.55851045 |
| 15 | adhesion of symbiont to host (GO:0044406) | 3.53734459 |
| 16 | negative regulation of axon guidance (GO:1902668) | 3.49690004 |
| 17 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.38800236 |
| 18 | adhesion of symbiont to host cell (GO:0044650) | 3.36308192 |
| 19 | virion attachment to host cell (GO:0019062) | 3.36308192 |
| 20 | extracellular fibril organization (GO:0043206) | 3.34819130 |
| 21 | glomerular filtration (GO:0003094) | 3.29397415 |
| 22 | regulation of sequestering of triglyceride (GO:0010889) | 3.26294905 |
| 23 | positive regulation of vascular permeability (GO:0043117) | 3.25583440 |
| 24 | cellular response to epinephrine stimulus (GO:0071872) | 3.21629739 |
| 25 | cell adhesion mediated by integrin (GO:0033627) | 3.20117385 |
| 26 | basement membrane organization (GO:0071711) | 3.19411078 |
| 27 | surfactant homeostasis (GO:0043129) | 3.19063177 |
| 28 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.15721973 |
| 29 | endothelial cell chemotaxis (GO:0035767) | 3.15539513 |
| 30 | triglyceride catabolic process (GO:0019433) | 3.12899326 |
| 31 | kidney mesenchyme development (GO:0072074) | 3.12559728 |
| 32 | regulation of plasminogen activation (GO:0010755) | 3.10454003 |
| 33 | collagen fibril organization (GO:0030199) | 3.09279594 |
| 34 | endothelium development (GO:0003158) | 3.09048983 |
| 35 | axon extension involved in axon guidance (GO:0048846) | 3.08719969 |
| 36 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.08719969 |
| 37 | extracellular matrix assembly (GO:0085029) | 3.08331700 |
| 38 | cardiac myofibril assembly (GO:0055003) | 3.08208969 |
| 39 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.05657901 |
| 40 | fibril organization (GO:0097435) | 3.05177155 |
| 41 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.04823160 |
| 42 | negative regulation of complement activation (GO:0045916) | 3.02747279 |
| 43 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.00244214 |
| 44 | complement activation, alternative pathway (GO:0006957) | 2.99871160 |
| 45 | positive regulation of receptor recycling (GO:0001921) | 2.98721867 |
| 46 | metanephric mesenchyme development (GO:0072075) | 2.97412035 |
| 47 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.92678744 |
| 48 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.88713714 |
| 49 | regulation of cholesterol storage (GO:0010885) | 2.84920889 |
| 50 | acylglycerol catabolic process (GO:0046464) | 2.84859078 |
| 51 | neutral lipid catabolic process (GO:0046461) | 2.84859078 |
| 52 | venous blood vessel morphogenesis (GO:0048845) | 2.82519459 |
| 53 | cAMP biosynthetic process (GO:0006171) | 2.82420967 |
| 54 | multicellular organismal catabolic process (GO:0044243) | 2.82148647 |
| 55 | wound healing, spreading of epidermal cells (GO:0035313) | 2.81673981 |
| 56 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.81643623 |
| 57 | regulation of p38MAPK cascade (GO:1900744) | 2.81491193 |
| 58 | collagen catabolic process (GO:0030574) | 2.79786069 |
| 59 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.78764443 |
| 60 | negative regulation of protein activation cascade (GO:2000258) | 2.78609043 |
| 61 | collagen metabolic process (GO:0032963) | 2.77324217 |
| 62 | multicellular organismal metabolic process (GO:0044236) | 2.74890392 |
| 63 | fibrinolysis (GO:0042730) | 2.74497449 |
| 64 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.72605824 |
| 65 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.71390373 |
| 66 | transcytosis (GO:0045056) | 2.70702064 |
| 67 | ovulation from ovarian follicle (GO:0001542) | 2.68970312 |
| 68 | coronary vasculature morphogenesis (GO:0060977) | 2.68802240 |
| 69 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.67527986 |
| 70 | tooth mineralization (GO:0034505) | 2.67089594 |
| 71 | response to epinephrine (GO:0071871) | 2.67021080 |
| 72 | chemical homeostasis within a tissue (GO:0048875) | 2.66214490 |
| 73 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.65815211 |
| 74 | myofibril assembly (GO:0030239) | 2.64288070 |
| 75 | sprouting angiogenesis (GO:0002040) | 2.63909035 |
| 76 | dermatan sulfate metabolic process (GO:0030205) | 2.63897978 |
| 77 | positive regulation of cholesterol efflux (GO:0010875) | 2.59358428 |
| 78 | lung vasculature development (GO:0060426) | 2.56650876 |
| 79 | positive regulation of lipid storage (GO:0010884) | 2.55375197 |
| 80 | negative regulation of protein autophosphorylation (GO:0031953) | 2.54927622 |
| 81 | * protein heterotrimerization (GO:0070208) | 2.53480874 |
| 82 | regulation of extracellular matrix disassembly (GO:0010715) | 2.53351541 |
| 83 | patterning of blood vessels (GO:0001569) | 2.52548621 |
| 84 | blood vessel endothelial cell migration (GO:0043534) | 2.51763356 |
| 85 | regulation of apoptotic cell clearance (GO:2000425) | 2.50422030 |
| 86 | cardiac muscle hypertrophy (GO:0003300) | 2.49146214 |
| 87 | dermatan sulfate biosynthetic process (GO:0030208) | 2.46198117 |
| 88 | cell differentiation involved in kidney development (GO:0061005) | 2.45691277 |
| 89 | opsonization (GO:0008228) | 2.44982799 |
| 90 | stress fiber assembly (GO:0043149) | 2.44816047 |
| 91 | cellular response to cadmium ion (GO:0071276) | 2.44304352 |
| 92 | sarcomere organization (GO:0045214) | 2.43105173 |
| 93 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.42056549 |
| 94 | glial cell migration (GO:0008347) | 2.41910560 |
| 95 | striated muscle hypertrophy (GO:0014897) | 2.39614025 |
| 96 | skin morphogenesis (GO:0043589) | 2.39344823 |
| 97 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.37755433 |
| 98 | regulation of the force of heart contraction (GO:0002026) | 2.36580062 |
| 99 | dopaminergic neuron differentiation (GO:0071542) | 2.36400335 |
| 100 | complement activation, classical pathway (GO:0006958) | 2.35820599 |
| 101 | epithelial cell-cell adhesion (GO:0090136) | 2.35778254 |
| 102 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.35722363 |
| 103 | chondroitin sulfate catabolic process (GO:0030207) | 2.35682938 |
| 104 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.35662095 |
| 105 | muscle hypertrophy (GO:0014896) | 2.35416911 |
| 106 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.34145428 |
| 107 | activation of protein kinase A activity (GO:0034199) | 2.33615240 |
| 108 | regulation of cardioblast differentiation (GO:0051890) | 2.33348782 |
| 109 | endocrine hormone secretion (GO:0060986) | 2.32882673 |
| 110 | cell migration involved in heart development (GO:0060973) | 2.32446451 |
| 111 | complement activation (GO:0006956) | 2.32194622 |
| 112 | extracellular matrix disassembly (GO:0022617) | 2.32005461 |
| 113 | negative regulation of fatty acid transport (GO:2000192) | 2.31672123 |
| 114 | cell-substrate junction assembly (GO:0007044) | 2.31021017 |
| 115 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.30774227 |
| 116 | regulation of glomerular filtration (GO:0003093) | 2.30372142 |
| 117 | cardiac muscle cell proliferation (GO:0060038) | 2.28394388 |
| 118 | ganglion development (GO:0061548) | 2.27758545 |
| 119 | positive regulation of fat cell differentiation (GO:0045600) | 2.27650471 |
| 120 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.26570187 |
| 121 | positive regulation of cholesterol transport (GO:0032376) | 2.26501385 |
| 122 | positive regulation of sterol transport (GO:0032373) | 2.26501385 |
| 123 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.26495412 |
| 124 | protein carboxylation (GO:0018214) | 2.26495412 |
| 125 | phagocytosis, recognition (GO:0006910) | 2.25588927 |
| 126 | smooth muscle tissue development (GO:0048745) | 2.25587599 |
| 127 | cardiac muscle adaptation (GO:0014887) | 2.25535391 |
| 128 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.25535391 |
| 129 | muscle hypertrophy in response to stress (GO:0003299) | 2.25535391 |
| 130 | regulation of complement activation (GO:0030449) | 2.25409673 |
| 131 | mesodermal cell differentiation (GO:0048333) | 2.25307303 |
| 132 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.25087817 |
| 133 | induction of positive chemotaxis (GO:0050930) | 2.24692589 |
| 134 | myoblast fusion (GO:0007520) | 2.24676943 |
| 135 | plasma lipoprotein particle clearance (GO:0034381) | 2.24302978 |
| 136 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.23547908 |
| 137 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.22951176 |
| 138 | chondrocyte proliferation (GO:0035988) | 2.22282187 |
| 139 | regulation of protein activation cascade (GO:2000257) | 2.22267668 |
| 140 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.21382335 |
| 141 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.21172901 |
| 142 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.20954188 |
| 143 | NADH metabolic process (GO:0006734) | 2.20757122 |
| 144 | regulation of gonadotropin secretion (GO:0032276) | 2.20688473 |
| 145 | glycosaminoglycan catabolic process (GO:0006027) | 2.20315618 |
| 146 | mesonephros development (GO:0001823) | 2.19898517 |
| 147 | import into cell (GO:0098657) | 2.19885458 |
| 148 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.19650138 |
| 149 | endothelial cell morphogenesis (GO:0001886) | 2.18984345 |
| 150 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.18671616 |
| 151 | negative regulation of cartilage development (GO:0061037) | 2.18285973 |
| 152 | diaphragm development (GO:0060539) | 2.17690422 |
| 153 | ethanol oxidation (GO:0006069) | 2.16964938 |
| 154 | metanephric epithelium development (GO:0072207) | 2.16959877 |
| 155 | hyaluronan catabolic process (GO:0030214) | 2.16807224 |
| 156 | angiogenesis involved in wound healing (GO:0060055) | 2.16506558 |
| 157 | type B pancreatic cell proliferation (GO:0044342) | 2.16407461 |
| 158 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.16324128 |
| 159 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.14277892 |
| 160 | muscle cell migration (GO:0014812) | 2.13316752 |
| 161 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.13221748 |
| 162 | desmosome organization (GO:0002934) | 2.12903201 |
| 163 | endodermal cell differentiation (GO:0035987) | 2.11924826 |
| 164 | negative regulation of vasculature development (GO:1901343) | 2.11913861 |
| 165 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.11376077 |
| 166 | * negative regulation of hemostasis (GO:1900047) | 2.10501572 |
| 167 | * negative regulation of blood coagulation (GO:0030195) | 2.10501572 |
| 168 | negative regulation of chemotaxis (GO:0050922) | 2.09729582 |
| 169 | apoptotic cell clearance (GO:0043277) | 2.09579098 |
| 170 | regulation of alkaline phosphatase activity (GO:0010692) | 2.09090117 |
| 171 | atrioventricular valve morphogenesis (GO:0003181) | 2.08927274 |
| 172 | glomerular visceral epithelial cell development (GO:0072015) | 11.8347859 |
| 173 | glomerular epithelial cell development (GO:0072310) | 10.5793085 |
| 174 | glomerular basement membrane development (GO:0032836) | 10.2478247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.96366344 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.77010411 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72423584 |
| 4 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.46642337 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.28462882 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.23738781 |
| 7 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20453885 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.19104886 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.19104886 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.15140800 |
| 11 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.13631639 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.04349485 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.03552750 |
| 14 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.01111330 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00046379 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.96063480 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94668248 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.92956727 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.92835730 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.90192640 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.87824763 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87581140 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.87459634 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.85348064 |
| 25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.84834543 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.84709435 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83331874 |
| 28 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.83247397 |
| 29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.80883875 |
| 30 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79909645 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.78221448 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.74543159 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74477658 |
| 34 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.74232542 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68045129 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.67434569 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63889228 |
| 38 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.60297802 |
| 39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.60028824 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59782623 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59544394 |
| 42 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.58514292 |
| 43 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.57797215 |
| 44 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.57583389 |
| 45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.55730561 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52953733 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51885148 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.50743225 |
| 49 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.49003390 |
| 50 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.48881210 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45338673 |
| 52 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45098511 |
| 53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41233861 |
| 54 | CJUN_26792858_Chip-Seq_BT549_Human | 1.40614834 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38358185 |
| 56 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37343668 |
| 57 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33951706 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31165405 |
| 59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.30653872 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30028086 |
| 61 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29926491 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27000982 |
| 63 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.26774131 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25883178 |
| 65 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25848720 |
| 66 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25759010 |
| 67 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24663363 |
| 68 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.23875547 |
| 69 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.22756868 |
| 70 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22522853 |
| 71 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21377917 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21298665 |
| 73 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21274175 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20645913 |
| 75 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18423701 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17477199 |
| 77 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14818155 |
| 78 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13433923 |
| 79 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.12425696 |
| 80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11659560 |
| 81 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11158135 |
| 82 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11078536 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11061872 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11061872 |
| 85 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09996156 |
| 86 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08432088 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07906992 |
| 88 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06677500 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06568642 |
| 90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.05702208 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05373517 |
| 92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05331822 |
| 93 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.04316484 |
| 94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04289670 |
| 95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04071283 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03563061 |
| 97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.03329356 |
| 98 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.03104359 |
| 99 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02845965 |
| 100 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02241891 |
| 101 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01513071 |
| 102 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.01462453 |
| 103 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01169543 |
| 104 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99424539 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99165278 |
| 106 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98719402 |
| 107 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98613549 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98610361 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98503504 |
| 110 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98344536 |
| 111 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97836934 |
| 112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97675684 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96466746 |
| 114 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.94697582 |
| 115 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94526078 |
| 116 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94268172 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93609211 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93290073 |
| 119 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92773523 |
| 120 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91839658 |
| 121 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90986692 |
| 122 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.90497022 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89752339 |
| 124 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88684136 |
| 125 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88416501 |
| 126 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87798438 |
| 127 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87052290 |
| 128 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86701063 |
| 129 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86701063 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86311768 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86086677 |
| 132 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85385888 |
| 133 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85121523 |
| 134 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84941262 |
| 135 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.84938481 |
| 136 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84557091 |
| 137 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84502611 |
| 138 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.84382017 |
| 139 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83607738 |
| 140 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.83367875 |
| 141 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83324241 |
| 142 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.83085250 |
| 143 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81487067 |
| 144 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.80723178 |
| 145 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80676720 |
| 146 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80433720 |
| 147 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79362227 |
| 148 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.79203667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.67438060 |
| 2 | MP0004272_abnormal_basement_membrane | 4.58175332 |
| 3 | MP0010368_abnormal_lymphatic_system | 4.13504340 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 3.62823064 |
| 5 | MP0005275_abnormal_skin_tensile | 3.38470805 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.10216722 |
| 7 | MP0005623_abnormal_meninges_morphology | 3.00272736 |
| 8 | MP0000013_abnormal_adipose_tissue | 2.91335825 |
| 9 | MP0001661_extended_life_span | 2.63986875 |
| 10 | MP0003724_increased_susceptibility_to | 2.55469765 |
| 11 | MP0005670_abnormal_white_adipose | 2.44625736 |
| 12 | MP0006054_spinal_hemorrhage | 2.26839688 |
| 13 | MP0003279_aneurysm | 2.22902175 |
| 14 | MP0004510_myositis | 2.21470806 |
| 15 | MP0001958_emphysema | 1.91552716 |
| 16 | MP0004084_abnormal_cardiac_muscle | 1.84274783 |
| 17 | MP0009384_cardiac_valve_regurgitation | 1.80271989 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.78119218 |
| 19 | MP0009840_abnormal_foam_cell | 1.74760907 |
| 20 | MP0002295_abnormal_pulmonary_circulatio | 1.70983130 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.57338189 |
| 22 | MP0005023_abnormal_wound_healing | 1.56708318 |
| 23 | MP0005508_abnormal_skeleton_morphology | 1.52273823 |
| 24 | MP0005257_abnormal_intraocular_pressure | 1.51573873 |
| 25 | MP0002971_abnormal_brown_adipose | 1.50317115 |
| 26 | MP0000230_abnormal_systemic_arterial | 1.48492421 |
| 27 | MP0000767_abnormal_smooth_muscle | 1.47832760 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.46955919 |
| 29 | MP0002060_abnormal_skin_morphology | 1.46320078 |
| 30 | MP0000579_abnormal_nail_morphology | 1.41394102 |
| 31 | MP0000462_abnormal_digestive_system | 1.40141353 |
| 32 | MP0008004_abnormal_stomach_pH | 1.39188031 |
| 33 | MP0003941_abnormal_skin_development | 1.39082877 |
| 34 | MP0002972_abnormal_cardiac_muscle | 1.39052565 |
| 35 | MP0003385_abnormal_body_wall | 1.38002922 |
| 36 | MP0002896_abnormal_bone_mineralization | 1.37903893 |
| 37 | MP0003011_delayed_dark_adaptation | 1.37558229 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.36362184 |
| 39 | MP0005330_cardiomyopathy | 1.35789882 |
| 40 | MP0004858_abnormal_nervous_system | 1.31841458 |
| 41 | MP0003942_abnormal_urinary_system | 1.30904175 |
| 42 | MP0004087_abnormal_muscle_fiber | 1.28229779 |
| 43 | MP0004130_abnormal_muscle_cell | 1.27616953 |
| 44 | MP0002254_reproductive_system_inflammat | 1.27109208 |
| 45 | MP0005595_abnormal_vascular_smooth | 1.26980125 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.25896947 |
| 47 | MP0003091_abnormal_cell_migration | 1.25874530 |
| 48 | MP0004036_abnormal_muscle_relaxation | 1.24912380 |
| 49 | MP0005666_abnormal_adipose_tissue | 1.21411800 |
| 50 | MP0002249_abnormal_larynx_morphology | 1.19930259 |
| 51 | MP0008775_abnormal_heart_ventricle | 1.17294616 |
| 52 | MP0000163_abnormal_cartilage_morphology | 1.15734801 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.15565804 |
| 54 | MP0003283_abnormal_digestive_organ | 1.15543966 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.14582769 |
| 56 | MP0000751_myopathy | 1.14529990 |
| 57 | MP0006138_congestive_heart_failure | 1.10795442 |
| 58 | MP0002136_abnormal_kidney_physiology | 1.10789637 |
| 59 | MP0003329_amyloid_beta_deposits | 1.10262271 |
| 60 | MP0000759_abnormal_skeletal_muscle | 1.10182423 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.09331890 |
| 62 | MP0003252_abnormal_bile_duct | 1.09237356 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.07257891 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.07184041 |
| 65 | MP0000750_abnormal_muscle_regeneration | 1.06839935 |
| 66 | MP0005164_abnormal_response_to | 1.06697415 |
| 67 | MP0000343_altered_response_to | 1.05706568 |
| 68 | MP0000749_muscle_degeneration | 1.05390894 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.05335817 |
| 70 | MP0002128_abnormal_blood_circulation | 1.05018970 |
| 71 | MP0000534_abnormal_ureter_morphology | 1.04437307 |
| 72 | MP0009250_abnormal_appendicular_skeleto | 1.01943791 |
| 73 | MP0005165_increased_susceptibility_to | 1.01379846 |
| 74 | MP0005332_abnormal_amino_acid | 1.01226747 |
| 75 | MP0010030_abnormal_orbit_morphology | 1.00438913 |
| 76 | MP0009115_abnormal_fat_cell | 0.99314120 |
| 77 | MP0000383_abnormal_hair_follicle | 0.99173590 |
| 78 | MP0003950_abnormal_plasma_membrane | 0.98954269 |
| 79 | MP0002135_abnormal_kidney_morphology | 0.98841343 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.98148729 |
| 81 | MP0002933_joint_inflammation | 0.98147256 |
| 82 | MP0002108_abnormal_muscle_morphology | 0.96795845 |
| 83 | MP0010630_abnormal_cardiac_muscle | 0.96074921 |
| 84 | MP0005360_urolithiasis | 0.95346699 |
| 85 | MP0005369_muscle_phenotype | 0.95246430 |
| 86 | MP0003075_altered_response_to | 0.94528648 |
| 87 | MP0000647_abnormal_sebaceous_gland | 0.93912062 |
| 88 | MP0005197_abnormal_uvea_morphology | 0.93716852 |
| 89 | MP0000566_synostosis | 0.92471248 |
| 90 | MP0003828_pulmonary_edema | 0.92317143 |
| 91 | MP0002115_abnormal_skeleton_extremities | 0.91346586 |
| 92 | MP0002282_abnormal_trachea_morphology | 0.90885262 |
| 93 | MP0001614_abnormal_blood_vessel | 0.90606549 |
| 94 | MP0005409_darkened_coat_color | 0.89910194 |
| 95 | MP0000604_amyloidosis | 0.89784154 |
| 96 | MP0003303_peritoneal_inflammation | 0.89630022 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.89354829 |
| 98 | MP0005334_abnormal_fat_pad | 0.89300131 |
| 99 | MP0002796_impaired_skin_barrier | 0.88137518 |
| 100 | MP0005390_skeleton_phenotype | 0.87854204 |
| 101 | MP0003690_abnormal_glial_cell | 0.86856662 |
| 102 | MP0005385_cardiovascular_system_phenoty | 0.85800216 |
| 103 | MP0001544_abnormal_cardiovascular_syste | 0.85800216 |
| 104 | MP0001542_abnormal_bone_strength | 0.85561582 |
| 105 | MP0000747_muscle_weakness | 0.84612740 |
| 106 | MP0003300_gastrointestinal_ulcer | 0.84608057 |
| 107 | MP0005620_abnormal_muscle_contractility | 0.83866867 |
| 108 | MP0000762_abnormal_tongue_morphology | 0.82287110 |
| 109 | MP0002106_abnormal_muscle_physiology | 0.81597325 |
| 110 | MP0002127_abnormal_cardiovascular_syste | 0.81453023 |
| 111 | MP0005365_abnormal_bile_salt | 0.79840670 |
| 112 | MP0005187_abnormal_penis_morphology | 0.79077327 |
| 113 | MP0001849_ear_inflammation | 0.78634346 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.78621547 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 0.78074262 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.77513609 |
| 117 | MP0001756_abnormal_urination | 0.77144873 |
| 118 | MP0004019_abnormal_vitamin_homeostasis | 0.76871260 |
| 119 | MP0001881_abnormal_mammary_gland | 0.76577017 |
| 120 | MP0003646_muscle_fatigue | 0.76241943 |
| 121 | MP0002098_abnormal_vibrissa_morphology | 0.76184609 |
| 122 | MP0001851_eye_inflammation | 0.75602771 |
| 123 | MP0000049_abnormal_middle_ear | 0.75567685 |
| 124 | MP0000537_abnormal_urethra_morphology | 0.75545121 |
| 125 | MP0004484_altered_response_of | 0.74780215 |
| 126 | MP0000249_abnormal_blood_vessel | 0.74438652 |
| 127 | MP0002113_abnormal_skeleton_development | 0.73995106 |
| 128 | MP0002970_abnormal_white_adipose | 0.73650491 |
| 129 | MP0003045_fibrosis | 0.73176516 |
| 130 | MP0005535_abnormal_body_temperature | 0.73048958 |
| 131 | MP0004381_abnormal_hair_follicle | 0.72491392 |
| 132 | MP0003195_calcinosis | 0.71615071 |
| 133 | MP0004085_abnormal_heartbeat | 0.71256188 |
| 134 | MP0003137_abnormal_impulse_conducting | 0.70899926 |
| 135 | MP0010678_abnormal_skin_adnexa | 0.70581401 |
| 136 | MP0003453_abnormal_keratinocyte_physiol | 0.70553300 |
| 137 | MP0004883_abnormal_blood_vessel | 0.69719313 |
| 138 | MP0001533_abnormal_skeleton_physiology | 0.69475631 |
| 139 | MP0001348_abnormal_lacrimal_gland | 0.68515789 |
| 140 | MP0009780_abnormal_chondrocyte_physiolo | 0.68180812 |
| 141 | MP0002168_other_aberrant_phenotype | 0.68059226 |
| 142 | MP0000733_abnormal_muscle_development | 0.66425608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mesangial abnormality (HP:0001966) | 7.27161055 |
| 2 | Focal segmental glomerulosclerosis (HP:0000097) | 6.23186225 |
| 3 | Nephritis (HP:0000123) | 4.77343950 |
| 4 | Glomerulosclerosis (HP:0000096) | 4.71595914 |
| 5 | Complement deficiency (HP:0004431) | 4.67677537 |
| 6 | Hypoalbuminemia (HP:0003073) | 4.62690768 |
| 7 | Abnormal albumin level (HP:0012116) | 4.62690768 |
| 8 | Premature rupture of membranes (HP:0001788) | 4.55881896 |
| 9 | Broad metatarsal (HP:0001783) | 4.26460482 |
| 10 | Abnormality of complement system (HP:0005339) | 4.22997289 |
| 11 | Glomerulonephritis (HP:0000099) | 3.99814972 |
| 12 | Deep venous thrombosis (HP:0002625) | 3.93048024 |
| 13 | Stage 5 chronic kidney disease (HP:0003774) | 3.92546232 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.81574883 |
| 15 | Aortic dissection (HP:0002647) | 3.55830311 |
| 16 | Protrusio acetabuli (HP:0003179) | 3.53818925 |
| 17 | Ankle contracture (HP:0006466) | 3.42159109 |
| 18 | Vertebral compression fractures (HP:0002953) | 3.38626498 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 3.31374929 |
| 20 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.23963572 |
| 21 | Aortic aneurysm (HP:0004942) | 3.21355332 |
| 22 | Hypoplasia of the iris (HP:0007676) | 3.12061472 |
| 23 | Neonatal respiratory distress (HP:0002643) | 3.11865121 |
| 24 | Cervical subluxation (HP:0003308) | 3.09538502 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.08488833 |
| 26 | Venous insufficiency (HP:0005293) | 3.05015247 |
| 27 | Follicular hyperkeratosis (HP:0007502) | 2.99268372 |
| 28 | Corneal erosion (HP:0200020) | 2.93887436 |
| 29 | Wrist flexion contracture (HP:0001239) | 2.92759566 |
| 30 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.87876130 |
| 31 | Lymphangioma (HP:0100764) | 2.86294880 |
| 32 | Atrophic scars (HP:0001075) | 2.84356547 |
| 33 | Venous abnormality (HP:0002624) | 2.80729365 |
| 34 | Overgrowth (HP:0001548) | 2.80589515 |
| 35 | Joint stiffness (HP:0001387) | 2.79570419 |
| 36 | Pulmonary artery stenosis (HP:0004415) | 2.76967651 |
| 37 | Nonimmune hydrops fetalis (HP:0001790) | 2.76517248 |
| 38 | Nephrotic syndrome (HP:0000100) | 2.72042808 |
| 39 | Cerebral aneurysm (HP:0004944) | 2.71953007 |
| 40 | Round ear (HP:0100830) | 2.69783073 |
| 41 | Coronal craniosynostosis (HP:0004440) | 2.69503064 |
| 42 | Increased connective tissue (HP:0009025) | 2.66137232 |
| 43 | Type 1 muscle fiber predominance (HP:0003803) | 2.61140867 |
| 44 | Mitral stenosis (HP:0001718) | 2.58500913 |
| 45 | Cardiovascular calcification (HP:0011915) | 2.58359922 |
| 46 | Hypoproteinemia (HP:0003075) | 2.58225929 |
| 47 | Lipoatrophy (HP:0100578) | 2.57841979 |
| 48 | Fragile skin (HP:0001030) | 2.53456973 |
| 49 | Slender build (HP:0001533) | 2.53265230 |
| 50 | Acanthosis nigricans (HP:0000956) | 2.52929884 |
| 51 | Bundle branch block (HP:0011710) | 2.48566578 |
| 52 | Atrial fibrillation (HP:0005110) | 2.47285675 |
| 53 | Sudden death (HP:0001699) | 2.46964559 |
| 54 | Hematuria (HP:0000790) | 2.45746433 |
| 55 | Short hallux (HP:0010109) | 2.43650157 |
| 56 | Hydroxyprolinuria (HP:0003080) | 2.37088194 |
| 57 | Abnormality of proline metabolism (HP:0010907) | 2.37088194 |
| 58 | Shallow orbits (HP:0000586) | 2.36932684 |
| 59 | Soft skin (HP:0000977) | 2.36385693 |
| 60 | Turricephaly (HP:0000262) | 2.35014067 |
| 61 | Spondylolisthesis (HP:0003302) | 2.31644858 |
| 62 | Vascular calcification (HP:0004934) | 2.30808319 |
| 63 | Mitral regurgitation (HP:0001653) | 2.27816451 |
| 64 | Aortic valve stenosis (HP:0001650) | 2.27712114 |
| 65 | Aortic regurgitation (HP:0001659) | 2.27481447 |
| 66 | Joint laxity (HP:0001388) | 2.27003975 |
| 67 | Biconcave vertebral bodies (HP:0004586) | 2.25430053 |
| 68 | Hypoplastic ischia (HP:0003175) | 2.25146451 |
| 69 | Vascular tortuosity (HP:0004948) | 2.24815054 |
| 70 | Abnormal atrioventricular conduction (HP:0005150) | 2.23369421 |
| 71 | Recurrent corneal erosions (HP:0000495) | 2.23182818 |
| 72 | Primary atrial arrhythmia (HP:0001692) | 2.22143930 |
| 73 | Oligomenorrhea (HP:0000876) | 2.21988436 |
| 74 | Abnormality of the ischium (HP:0003174) | 2.21566778 |
| 75 | Striae distensae (HP:0001065) | 2.21478171 |
| 76 | Genu recurvatum (HP:0002816) | 2.19567901 |
| 77 | Aneurysm (HP:0002617) | 2.19509175 |
| 78 | Hematochezia (HP:0002573) | 2.17433495 |
| 79 | Muscle fiber splitting (HP:0003555) | 2.17231846 |
| 80 | Proteinuria (HP:0000093) | 2.16630479 |
| 81 | Hyporeflexia of lower limbs (HP:0002600) | 2.16468192 |
| 82 | Supraventricular arrhythmia (HP:0005115) | 2.16057886 |
| 83 | Polycythemia (HP:0001901) | 2.15677461 |
| 84 | Supraventricular tachycardia (HP:0004755) | 2.14985912 |
| 85 | Skin nodule (HP:0200036) | 2.14897754 |
| 86 | Arterial tortuosity (HP:0005116) | 2.13874063 |
| 87 | Tubular atrophy (HP:0000092) | 2.13820880 |
| 88 | Peritonitis (HP:0002586) | 2.13801994 |
| 89 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13486280 |
| 90 | Osteolytic defects of the hand bones (HP:0009699) | 2.13486280 |
| 91 | Hypertriglyceridemia (HP:0002155) | 2.11660658 |
| 92 | Thin bony cortex (HP:0002753) | 2.11268940 |
| 93 | Abnormality of Sharpey fibers (HP:0100685) | 2.11214193 |
| 94 | Prolonged partial thromboplastin time (HP:0003645) | 2.10976256 |
| 95 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.10731329 |
| 96 | Metaphyseal dysplasia (HP:0100255) | 2.09186976 |
| 97 | Obstructive sleep apnea (HP:0002870) | 2.08497127 |
| 98 | Bladder diverticulum (HP:0000015) | 2.08034892 |
| 99 | Atrioventricular block (HP:0001678) | 2.05576738 |
| 100 | Hypophosphatemia (HP:0002148) | 2.04508409 |
| 101 | Distal lower limb amyotrophy (HP:0008944) | 2.04347710 |
| 102 | Polar cataract (HP:0010696) | 2.03624279 |
| 103 | Joint hemorrhage (HP:0005261) | 2.02794469 |
| 104 | Abnormality of dentin (HP:0010299) | 2.02003290 |
| 105 | Axonal loss (HP:0003447) | 2.01675005 |
| 106 | Increased variability in muscle fiber diameter (HP:0003557) | 2.01080466 |
| 107 | Blue sclerae (HP:0000592) | 2.00707790 |
| 108 | Emphysema (HP:0002097) | 1.99974589 |
| 109 | Heart block (HP:0012722) | 1.98287958 |
| 110 | Spinal rigidity (HP:0003306) | 1.98176265 |
| 111 | Coxa vara (HP:0002812) | 1.97531548 |
| 112 | Nuclear cataract (HP:0100018) | 1.97451474 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 1.96353095 |
| 114 | Knee flexion contracture (HP:0006380) | 1.96340037 |
| 115 | Bradycardia (HP:0001662) | 1.92836282 |
| 116 | Persistence of primary teeth (HP:0006335) | 1.92395659 |
| 117 | Prominent supraorbital ridges (HP:0000336) | 1.91917896 |
| 118 | Ventricular tachycardia (HP:0004756) | 1.91784279 |
| 119 | Chondrocalcinosis (HP:0000934) | 1.90599882 |
| 120 | Increased corneal curvature (HP:0100692) | 1.89195586 |
| 121 | Keratoconus (HP:0000563) | 1.89195586 |
| 122 | Advanced eruption of teeth (HP:0006288) | 1.89090392 |
| 123 | Amyloidosis (HP:0011034) | 1.87221757 |
| 124 | Hyperextensible skin (HP:0000974) | 1.86357515 |
| 125 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.85697556 |
| 126 | Pterygium (HP:0001059) | 1.85690326 |
| 127 | Wormian bones (HP:0002645) | 1.84777337 |
| 128 | Dysostosis multiplex (HP:0000943) | 1.84245622 |
| 129 | Aplasia cutis congenita (HP:0001057) | 1.83820492 |
| 130 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82076880 |
| 131 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82076880 |
| 132 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82076880 |
| 133 | Generalized amyotrophy (HP:0003700) | 1.81406451 |
| 134 | Ectopia lentis (HP:0001083) | 1.80841103 |
| 135 | Mucopolysacchariduria (HP:0008155) | 1.80801428 |
| 136 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80801428 |
| 137 | Mitral valve prolapse (HP:0001634) | 1.80631648 |
| 138 | Hypoventilation (HP:0002791) | 1.79032886 |
| 139 | Abnormality of the calf musculature (HP:0001430) | 1.78709387 |
| 140 | Nonprogressive disorder (HP:0003680) | 1.78680852 |
| 141 | Preaxial foot polydactyly (HP:0001841) | 1.78333433 |
| 142 | Neonatal short-limb short stature (HP:0008921) | 1.77385554 |
| 143 | Hip contracture (HP:0003273) | 1.75741405 |
| 144 | Limited hip movement (HP:0008800) | 1.75279232 |
| 145 | Alopecia of scalp (HP:0002293) | 1.75250879 |
| 146 | Craniofacial hyperostosis (HP:0004493) | 1.75060393 |
| 147 | Femoral bowing (HP:0002980) | 1.72333235 |
| 148 | Anomalous pulmonary venous return (HP:0010772) | 1.71906955 |
| 149 | Myocardial infarction (HP:0001658) | 1.70805286 |
| 150 | Hypoalphalipoproteinemia (HP:0003233) | 1.70656893 |
| 151 | Xanthomatosis (HP:0000991) | 1.70527659 |
| 152 | Elbow flexion contracture (HP:0002987) | 1.70417200 |
| 153 | Concave nail (HP:0001598) | 1.70388475 |
| 154 | Down-sloping shoulders (HP:0200021) | 1.70306036 |
| 155 | Dilatation of the ascending aorta (HP:0005111) | 1.69920003 |
| 156 | Rapidly progressive (HP:0003678) | 1.68878878 |
| 157 | Synostosis involving the elbow (HP:0003938) | 1.66411770 |
| 158 | Humeroradial synostosis (HP:0003041) | 1.66411770 |
| 159 | Distal lower limb muscle weakness (HP:0009053) | 1.66280772 |
| 160 | Abnormality of the pulmonary veins (HP:0011718) | 1.65581758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.92528571 |
| 2 | TIE1 | 4.55141773 |
| 3 | EPHB2 | 4.52062691 |
| 4 | TGFBR2 | 3.09798717 |
| 5 | SIK1 | 2.82409855 |
| 6 | WNK4 | 2.69013395 |
| 7 | MYLK | 2.68489468 |
| 8 | ERN1 | 2.09766078 |
| 9 | BLK | 2.04705498 |
| 10 | FER | 1.97257412 |
| 11 | EPHB1 | 1.93378423 |
| 12 | EPHA3 | 1.91513793 |
| 13 | MAP3K6 | 1.91490836 |
| 14 | PDGFRA | 1.81669446 |
| 15 | CAMK1G | 1.66151515 |
| 16 | TESK1 | 1.62005329 |
| 17 | CASK | 1.57919024 |
| 18 | TTN | 1.57781136 |
| 19 | LATS1 | 1.53668349 |
| 20 | TRIB3 | 1.52034787 |
| 21 | DDR2 | 1.49044218 |
| 22 | INSRR | 1.43267887 |
| 23 | CAMK1D | 1.40637656 |
| 24 | FGFR4 | 1.39993636 |
| 25 | GRK1 | 1.38739112 |
| 26 | STK39 | 1.24455364 |
| 27 | JAK1 | 1.20649640 |
| 28 | TBK1 | 1.20465541 |
| 29 | PAK2 | 1.19571960 |
| 30 | PAK3 | 1.13647963 |
| 31 | MAPKAPK3 | 1.13311454 |
| 32 | PIK3CA | 1.12334817 |
| 33 | PAK4 | 1.12109214 |
| 34 | MAP2K1 | 1.11604921 |
| 35 | MST1R | 1.10517222 |
| 36 | PRKD2 | 1.08475846 |
| 37 | PTK6 | 1.07312201 |
| 38 | ROCK1 | 1.06168559 |
| 39 | NEK9 | 1.03618950 |
| 40 | TAOK2 | 1.03499923 |
| 41 | OXSR1 | 0.98686068 |
| 42 | TGFBR1 | 0.98008564 |
| 43 | MOS | 0.96693360 |
| 44 | ICK | 0.94860961 |
| 45 | IRAK1 | 0.90945430 |
| 46 | NTRK1 | 0.90284475 |
| 47 | EEF2K | 0.89152054 |
| 48 | MAPK4 | 0.87369613 |
| 49 | MAP3K7 | 0.87319487 |
| 50 | IRAK3 | 0.86917858 |
| 51 | PTK2B | 0.85699076 |
| 52 | MAPK7 | 0.84968817 |
| 53 | ARAF | 0.84898296 |
| 54 | MET | 0.84410732 |
| 55 | GSK3A | 0.83547020 |
| 56 | TRPM7 | 0.83247776 |
| 57 | RPS6KA2 | 0.82970981 |
| 58 | LATS2 | 0.82755869 |
| 59 | WNK1 | 0.82568588 |
| 60 | PRKAA2 | 0.82269306 |
| 61 | MAPK15 | 0.81094574 |
| 62 | PKN2 | 0.81084503 |
| 63 | PKN1 | 0.80941881 |
| 64 | PRKCE | 0.80441358 |
| 65 | MTOR | 0.80362620 |
| 66 | PTK2 | 0.79134236 |
| 67 | NTRK3 | 0.79007265 |
| 68 | KIT | 0.78032518 |
| 69 | OBSCN | 0.75172131 |
| 70 | HIPK2 | 0.74095318 |
| 71 | MAP2K3 | 0.73743297 |
| 72 | STK38 | 0.72407587 |
| 73 | DMPK | 0.70859399 |
| 74 | PDPK1 | 0.69834221 |
| 75 | ZAP70 | 0.69002215 |
| 76 | PHKG2 | 0.67699222 |
| 77 | PHKG1 | 0.67699222 |
| 78 | LIMK1 | 0.67300083 |
| 79 | PIK3CG | 0.67071196 |
| 80 | MAPK12 | 0.67025062 |
| 81 | GRK5 | 0.66576490 |
| 82 | GRK7 | 0.65973151 |
| 83 | PIM2 | 0.65707512 |
| 84 | PDGFRB | 0.63680654 |
| 85 | DAPK3 | 0.62744623 |
| 86 | MAP3K14 | 0.61314555 |
| 87 | BMX | 0.60001260 |
| 88 | CAMK2B | 0.59625240 |
| 89 | PRKG2 | 0.59624461 |
| 90 | RPS6KL1 | 0.59204570 |
| 91 | RPS6KC1 | 0.59204570 |
| 92 | STK38L | 0.58455597 |
| 93 | DAPK2 | 0.57889471 |
| 94 | FGFR2 | 0.57665446 |
| 95 | SIK3 | 0.57329922 |
| 96 | CSK | 0.57202735 |
| 97 | MAP2K2 | 0.56977317 |
| 98 | PRKD3 | 0.55643435 |
| 99 | ROCK2 | 0.53623550 |
| 100 | PRKAA1 | 0.53421601 |
| 101 | ADRBK1 | 0.53243262 |
| 102 | RET | 0.52931100 |
| 103 | RPS6KA6 | 0.52161388 |
| 104 | FRK | 0.52141122 |
| 105 | RIPK1 | 0.51527454 |
| 106 | PRKD1 | 0.51417246 |
| 107 | ERBB4 | 0.50085637 |
| 108 | SRC | 0.50010738 |
| 109 | MAP3K11 | 0.49818706 |
| 110 | AKT3 | 0.49534413 |
| 111 | CAMK4 | 0.48043668 |
| 112 | JAK2 | 0.47438891 |
| 113 | CAMK2G | 0.46406444 |
| 114 | CDC42BPA | 0.45367521 |
| 115 | IGF1R | 0.45123957 |
| 116 | IRAK2 | 0.45093752 |
| 117 | CAMK2D | 0.43203601 |
| 118 | MAP3K13 | 0.42259508 |
| 119 | EPHA2 | 0.41632761 |
| 120 | NTRK2 | 0.41631453 |
| 121 | PRPF4B | 0.41010736 |
| 122 | MAP3K1 | 0.40459102 |
| 123 | BMPR1B | 0.39503757 |
| 124 | INSR | 0.38919640 |
| 125 | MUSK | 0.38716170 |
| 126 | PRKACG | 0.38217830 |
| 127 | MARK1 | 0.37574193 |
| 128 | LMTK2 | 0.37369445 |
| 129 | NLK | 0.37299413 |
| 130 | SIK2 | 0.35151564 |
| 131 | CAMK1 | 0.34872350 |
| 132 | FGFR3 | 0.33512540 |
| 133 | FGFR1 | 0.33469185 |
| 134 | ABL2 | 0.33329805 |
| 135 | MAP3K3 | 0.32096777 |
| 136 | MARK2 | 0.32078482 |
| 137 | ADRBK2 | 0.31798523 |
| 138 | TYK2 | 0.30934658 |
| 139 | PINK1 | 0.29858417 |
| 140 | JAK3 | 0.29384740 |
| 141 | PRKCH | 0.29310557 |
| 142 | PDK2 | 0.29196781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.76103216 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63021325 |
| 3 | Focal adhesion_Homo sapiens_hsa04510 | 2.24117043 |
| 4 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.14568278 |
| 5 | Prion diseases_Homo sapiens_hsa05020 | 2.09360016 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.92301142 |
| 7 | Axon guidance_Homo sapiens_hsa04360 | 1.90090644 |
| 8 | Amoebiasis_Homo sapiens_hsa05146 | 1.89440996 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81443018 |
| 10 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.78406843 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.64891557 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61946924 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.57975699 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57722363 |
| 15 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.57179626 |
| 16 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.55846024 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.54630427 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.50292896 |
| 19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47686233 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.43568787 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40111194 |
| 22 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.36805331 |
| 23 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.32079593 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31612517 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30300997 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.28585368 |
| 27 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.19411695 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19138907 |
| 29 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14412686 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.13503544 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.12856497 |
| 32 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.12722399 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.11987787 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11811855 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11728871 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.09367007 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08226415 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.07167751 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06563471 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02827290 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01667863 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95478974 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95207538 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95198629 |
| 45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.93853430 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93674994 |
| 47 | Adherens junction_Homo sapiens_hsa04520 | 0.93615004 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92581724 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92229616 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90004750 |
| 51 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.87883873 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87778236 |
| 53 | Melanoma_Homo sapiens_hsa05218 | 0.86127100 |
| 54 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.86047638 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84928672 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84383353 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84338592 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83955183 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83335611 |
| 60 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83180554 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.82746807 |
| 62 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.81051470 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.79707911 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78649559 |
| 65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.78331544 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76314281 |
| 67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76184952 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75551858 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74825952 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74762496 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74692820 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72891193 |
| 73 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.72325861 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71705914 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70570814 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70176030 |
| 77 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.69996251 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69647713 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.68553142 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66359868 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65852923 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64939736 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64873428 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63936358 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63446447 |
| 86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62751004 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61981475 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61742616 |
| 89 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61374987 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59563530 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.59327982 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59313925 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58971880 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.58600768 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57929082 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.56854016 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56073302 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.55331925 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55216711 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53811067 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53642205 |
| 102 | Gap junction_Homo sapiens_hsa04540 | 0.52985361 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.52178115 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51857725 |
| 105 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51845352 |
| 106 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51532005 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.51460907 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.51174170 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50394203 |
| 110 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50192919 |
| 111 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48630634 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48014867 |
| 113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45930814 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.45798692 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45453445 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45420430 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44913773 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44109723 |
| 119 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43546530 |
| 120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42962366 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42895952 |
| 122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.42810015 |
| 123 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42697717 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41548246 |
| 125 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41335299 |
| 126 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41149762 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40582838 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.40033179 |
| 129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39957608 |
| 130 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39582947 |
| 131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39546835 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39279083 |
| 133 | Lysosome_Homo sapiens_hsa04142 | 0.38914433 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37742617 |
| 135 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37453272 |
| 136 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37252424 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37222957 |
| 138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36755308 |
| 139 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36546748 |

